The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(1-(4-Methoxybenzyl)-1H-1,2,3-triazol-4-yl)-N-(6-(4-(5-(2-(pyridin-2-yl)acetamido)-1,3,4-thiadiazol-2-yl)butyl)pyridazin-3-yl)-propanamide ID: ALA4554275
PubChem CID: 155556555
Max Phase: Preclinical
Molecular Formula: C30H32N10O3S
Molecular Weight: 612.72
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(Cn2cc(CCC(=O)Nc3ccc(CCCCc4nnc(NC(=O)Cc5ccccn5)s4)nn3)nn2)cc1
Standard InChI: InChI=1S/C30H32N10O3S/c1-43-25-13-9-21(10-14-25)19-40-20-24(35-39-40)12-16-27(41)32-26-15-11-22(34-36-26)6-2-3-8-29-37-38-30(44-29)33-28(42)18-23-7-4-5-17-31-23/h4-5,7,9-11,13-15,17,20H,2-3,6,8,12,16,18-19H2,1H3,(H,32,36,41)(H,33,38,42)
Standard InChI Key: HODCLPKLNRPKCE-UHFFFAOYSA-N
Molfile:
RDKit 2D
44 48 0 0 0 0 0 0 0 0999 V2000
4.1883 -7.3475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8963 -6.9361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6046 -7.3469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6046 -8.1664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8989 -8.5729 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1883 -8.1675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3127 -8.5740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0207 -8.1664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7329 -8.5740 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4410 -8.1664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5261 -7.3498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3277 -7.1808 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7351 -7.8884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1876 -8.4977 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.5546 -7.8884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9622 -7.1804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7817 -7.1804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1935 -6.4723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0129 -6.4723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4209 -5.7643 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2369 -5.7654 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6447 -6.4738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2419 -7.1779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4231 -7.1847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4642 -6.4738 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8760 -5.7657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6954 -5.7657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1031 -5.0535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9225 -5.0535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4037 -4.3920 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1819 -4.6461 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1819 -5.4650 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.4037 -5.7150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8900 -5.8727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5980 -5.4650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5984 -4.6455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3081 -4.2364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0164 -4.6484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0187 -5.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3105 -5.8752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7245 -4.2366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.7245 -3.4212 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4642 -5.0535 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0207 -7.3469 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
11 10 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 1 0
13 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
20 19 2 0
21 20 1 0
22 21 2 0
23 22 1 0
24 23 2 0
19 24 1 0
22 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
30 29 1 0
30 31 2 0
31 32 1 0
32 33 1 0
33 29 2 0
32 34 1 0
34 35 1 0
36 35 2 0
37 36 1 0
38 37 2 0
39 38 1 0
40 39 2 0
35 40 1 0
38 41 1 0
41 42 1 0
26 43 2 0
8 44 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 612.72Molecular Weight (Monoisotopic): 612.2380AlogP: 3.69#Rotatable Bonds: 15Polar Surface Area: 162.59Molecular Species: NEUTRALHBA: 12HBD: 2#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.94CX Basic pKa: 4.33CX LogP: 3.24CX LogD: 2.71Aromatic Rings: 5Heavy Atoms: 44QED Weighted: 0.17Np Likeness Score: -1.99
References 1. Xu X, Kuang Z, Han J, Meng Y, Li L, Luan H, Xu P, Wang J, Luo C, Ding H, Li Z, Bian J.. (2019) Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors., 62 (21): [PMID:31603674 ] [10.1021/acs.jmedchem.9b01035 ]